Osteoblastic Monocyte Chemoattractant Protein-1 (MCP-1) Mediation of Parathyroid Hormone's Anabolic Actions in Bone Implicates TGF-β Signaling.

[1]  V. Kolupaeva,et al.  Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1‐34) in Mice , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Xuedong Zhou,et al.  Aberrant activation of latent transforming growth factor-β initiates the onset of temporomandibular joint osteoarthritis , 2018, Bone Research.

[3]  P. Stern,et al.  Editorial: Chemokines and Bone , 2018, Front. Endocrinol..

[4]  J. Westendorf,et al.  The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  J. Siddiqui,et al.  Catabolic Effects of Human PTH (1–34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism , 2017, Scientific Reports.

[6]  Yi-Shiuan Liu,et al.  Intermittent Administration of Parathyroid Hormone 1–34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ , 2017, International journal of molecular sciences.

[7]  J. Siddiqui,et al.  CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone , 2017, Front. Endocrinol..

[8]  Fang Wang,et al.  Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients. , 2016, Clinical laboratory.

[9]  J. Siddiqui,et al.  Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. , 2016, Physiology.

[10]  Mahmoud M. Bakr,et al.  CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells , 2016, Journal of cellular biochemistry.

[11]  S. Shapses,et al.  Serum monocyte chemokine protein-1 levels before and after parathyroidectomy in patients with primary hyperparathyroidism. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  E. Shimizu,et al.  Monocyte chemoattractant protein‐1 is a mediator of the anabolic action of parathyroid hormone on bone , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  J. Kanis,et al.  Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Bilezikian,et al.  Catabolic and anabolic actions of parathyroid hormone on the skeleton , 2011, Journal of endocrinological investigation.

[15]  F. Frassica,et al.  Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. , 2010, Cell stem cell.

[16]  J. Siddiqui,et al.  8,8″-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8″-biapigeninyl in ovariectomized mice , 2010, Molecular and Cellular Endocrinology.

[17]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  Y. Toyama,et al.  MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. , 2009, Biochemical and biophysical research communications.

[19]  Yi Tang,et al.  TGF-β1-induced Migration of Bone Mesenchymal Stem Cells Couples Bone Resorption and Formation , 2009, Nature Medicine.

[20]  M. Mack,et al.  Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis , 2009, Nature Medicine.

[21]  L. Qin,et al.  Parathyroid Hormone Stimulates Osteoblastic Expression of MCP-1 to Recruit and Increase the Fusion of Pre/Osteoclasts* , 2007, Journal of Biological Chemistry.

[22]  D. Notterman,et al.  Determination of Dual Effects of Parathyroid Hormone on Skeletal Gene Expression in Vivo by Microarray and Network Analysis* , 2007, Journal of Biological Chemistry.

[23]  G. Xiao,et al.  CCR2 expression correlates with prostate cancer progression , 2007, Journal of cellular biochemistry.

[24]  G. Roodman,et al.  Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. , 2007, Cancer research.

[25]  C. Selinger,et al.  MCP-1-induced Human Osteoclast-like Cells Are Tartrate-resistant Acid Phosphatase, NFATc1, and Calcitonin Receptor-positive but Require Receptor Activator of NFκB Ligand for Bone Resorption* , 2006, Journal of Biological Chemistry.

[26]  R. Ritchie,et al.  TGF-beta regulates the mechanical properties and composition of bone matrix. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Taichman,et al.  Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. , 2005, Endocrinology.

[28]  N. Morrison,et al.  MCP-1 Is Induced by Receptor Activator of Nuclear Factor-κB Ligand, Promotes Human Osteoclast Fusion, and Rescues Granulocyte Macrophage Colony-stimulating Factor Suppression of Osteoclast Formation* , 2005, Journal of Biological Chemistry.

[29]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[30]  Mary L Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.

[31]  S. Ali,et al.  Leucocyte chemotaxis: Examination of mitogen‐activated protein kinase and phosphoinositide 3‐kinase activation by Monocyte Chemoattractant Proteins‐1, ‐2, ‐3 and ‐4 , 2002, Clinical and experimental immunology.

[32]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[33]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[34]  R. Kumar,et al.  Parathyroid Hormone Regulates Transforming Growth Factor β1 and β2 Synthesis in Osteoblasts Via Divergent Signaling Pathways , 2000 .

[35]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[36]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Gong,et al.  Monocyte Chemotactic Protein-2 (MCP-2) Uses CCR1 AND CCR2B as Its Functional Receptors* , 1997, The Journal of Biological Chemistry.

[38]  C. Y. Wang,et al.  Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. , 1995, Endocrinology.

[39]  R. Lindsay,et al.  Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.

[40]  J. Orloff,et al.  Parathyroid hormone-related protein modulates the effect of transforming growth factor-beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells. , 1989, Endocrinology.

[41]  L. Bonewald,et al.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. , 1989, Biochemical and biophysical research communications.

[42]  E. Canalis,et al.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Rodan,et al.  Direct action of the parathyroid hormone-like human hypercalcemic factor on bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  N L Fazzalari,et al.  Gene expression profile of the bone microenvironment in human fragility fracture bone. , 2009, Bone.

[46]  Sarah L Dallas,et al.  Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. , 2002, The Journal of biological chemistry.